Thomis Jeff
Non-Executive Director
clinical research
UF College of Pharmacy
Netherlands
Biography
Dr. Thomis has 40 years of experience in the clinical and commercial development of new medicines, including 20 years at executive level with Quintiles where he was most recently Chairman of the American Management Board. From 1997-2010, as President of European Clinical Development and then as President of Global Clinical Development, Dr. Thomis was responsible for creating a global division of 12,000 people across 59 countries. Dr. Thomis joined Quintiles in 1997 following 20 years at Bristol-Myers Squibb, where he held senior positions in Clinical Research and Medical Development across Europe and the U.S. Dr. Thomis is a partner in OxOnc and and has previously held board positions at Idis Pharma (2013-15), PDP Courier Services (2012-13) in addition to America (2010-2012) and Quintiles EMEA (2003-2005). Dr Thomis currently sits on the board of Cesca Therapeutics, a Nasdaq traded company, and is a Senior Advisor to GHO Capital.
Research Interest
Biochemistry, Pharmacy, Biotechnology, Clinical Research
